|
List of Jounal Titles
A to Z index of Journal Title. Choose a letter.
Kidney and Dialysis
46
- Pathogenic mechanism of gastric mucosal lesion in patient undergoing hemodialysis.
- Surgical approaches to digestive diseases in dialysis patients.
- Laparoscopic surgery for gastroenterological diseases in hemodialyzed patients.
- Perioperative management of digestive organ diseases in dialysis patients.
- Surgical treatment of spinal disorders associated with long term hemodialysis.
- Relapse case of secondary hyperparathyroidism after total parathyroidectomy with autotransplantation for secondary hyperparathyroidism.
- Case study of secondary hyperparathyroidism with ectopic parathyroid.
- 3 cases of mediastinal parathyroid glands in patients on hemodialysis.
- Effect of low reactive level laser therapy on arm pain associated with shunting during hemodialysis.
- Indications for percutaneous transluminal angioplasty (PTA) and influence on the duration of patency.
- Use of auto suture microclip anastomosis device (VCS) for hemodialysis vascular access.
- A rare case of poly-urethane vascular access graft (Thoratec) obstruction.
- Complicatons of prosthetic fistula using HDS grafts.
- Tuberculosis of the sternoclavicular joint in a patient undergoing maintenance hemodialysis.
- Complete remission of lymph node metastasis in the pulmonary hilum from renal cell carcinoma: A case report.
- Recovery of renal function by release of obstruction continueing for 5 month due to ureteral ligature.
- Retroperitoneal hemorrhage due to cystic rupture in acquired cystic disease of kidney: a case report.
- Renal cell carcinoma with acquired cysts in hemodialysis patients.
- A case of pheocromocytoma in a patient with chronic renal failure.
- Laparoscopic repair of an indirect inguinal hernial sac's rupture with extravasation on continuous ambulatory peritoneal dialysis-report of a case.
- A case of spontaneous splenic rupture in hemodialysis patient.
- Therapeutic strategy for sclerosing encapsulating peritonitis.
- Efonidipine hydrochloride might have elevated the tacrolimus concentration in a renal transplant patient: A case report.
- Case report of liver cirrhosis patient with acute renal failure who underwent living related liver transplantation.
- Upper digestive tract bleeding of chronic renal failure.
- The study of operations for gastrointestinal bleeding in dialysis patients.
- Clinical study on the emergent abdominal surgery in hemodialysis patients.
- The study of gastrectomy in chronic hemodialysis patients.
- The study of abdominal operations under general anesthesia in chronic hemodialysis patients.
- Study on abdominal surgery in patients on maintenance hemodialysis due to chronic renal failure and after renal transplantation.
1
- Easy kidney disease course. 1. Structure of kidney and urinary tract Dissection and tissues and vascular systems.
- Progress in the study on IgA nephropathy-overview.
- Epidemiologic analysis of IgA nephropathy in Japan.
- The impact of urinary screening of school children of IgA nephrophathy.
- Initiation on patients with IgA nephropathy.
- Mechanisms of progressive renal injury in IgA nephrophathy.
- Mechanism of pathogenesis and progression.
- Steroid therapy of IgA nephritis in acute stage has a fevorable outcome.
- Age-related glomerulointerstitial lesions in IgA nephropathy.
- The heterogeneity on IgA nephropathy.
- Posttransplant IgA nephropathy.
- Treatment of childhood IgA nephropathy.
- Indication for steroid therapy in adult IgA nephropathy.
- Anti-platelet therapy on IgA nephropathy.
- Treatment objective in IgA nephropathy.
- ACE inhibition as a strategy for the progression of IgA nephropathy.
- Potential therapeutic approach utilizing molecular biological technique.
- New horizon of experimental and spontaneous animal model of IgA nephropathy.
- Recent molecular approach to the pathogenesis of IgA nephropathy in patients.
- What should be studied from biopsy findings on kidneys ? No.1. A case of nephrotic syndrome with effective LDL apheresis after diagnosis of focal sclerosing glomerulopathy in recurrence.
- Clinical effects of long-term intravenous administration of calcitriol(Ro21-5535) on secondary hyperparathyroidism.
2
- Regulation of water and electrolyte metabolism. Overview.
- Molecular basis of PTH action on the kidney.
- Aldosterone action on renal tubules.
- Vasopressin action on renal tubules.
- Water and electrolytes handling of angiotensin II.
- Water and electrolyte regulation by the natriuretic peptide family.
- Regulation of water-electrolytes balance by dopamine and insulin.
- Renal tubular action of diuretics.
- Bartter's syndrome and related disoeders.
- Parathyroid dysfunction and related diseases.
- Primary aldosteronism and related diseases.
- Diabetes insipidus and diabetes insipidus-like disease.
- Syndrome of inappropriate secretion of ADH and the related diseases.
- Disorders of mineral concentration on end stage renal disease(ESRD).
- Fluid and electrolyte control in hemodialysis patients.
- Effect of calcium carbonate tablet on chronic renal failure.
- Suppression of PTH and clinical evaluation of intravenous administered calcitriol(Ro 21-5535) on secondary hyperparathyroidism.
- An autopsy case of nephrotic syndrome accompanied with severe complications in various organs.
3
- Illustrated easy kidney disease course. 3. Functions of the kidney. 2) Functions of the malpighian tubule.
- Significance and problems Quality of Life research.
- Health-related Quality of Life measures used in clinical evaluation and the SF-36 Japanese version.
- Kidney-disease-targeted measures of quality of life: The KDQOL.
- Malignant diseases and quality of life in urology.
- QOL of the refractory nephrotic syndrome.
- QOL in patients with predialysis chronic renal failure.
- Quality of life in continuous ambulatory peritoneal dialysis patients.
- Health-related quality of life(HQOL) of hemodialysis patients.
- Quality of life among renal-transplant recipients.
- QOL in diabetic nephropathy.
- QOL in renal uropathy. QOL in infant kidney diseases.
- Quality of life assessment in bladder outlet obstruction.
- Quality of life in patients with urogenital cancer and urinary diversion.
- The influence of barnidipine hydrochloride on peritoneal dialysate.
- Clinical effect by intravenous administration of Ro21-5535(calcitriol) on secondary hyperparathyroidism.
- A case of acute renal failure associated with primary malignant lymphoma of the uterus.
- A case of CAPD patient with nosocomial "Tunnel Infections" of methicillin-resistant Staphylococcus aureus.
4
- Illustration, easy kidney disease course 4. Functions of the kidney 3). Endocrine functions.
- Pathophysiology of acute renal failure.
- Acute renal failure and apoptosis.
- Cell cycle in acute renal failure.
- Therapeutic treatment of acute and chronic renal failure by hepatocyte growth factor.
- Topics in diabetes mellitus.
- Pathogenesis of diabetic nephropathy.
- Pathogenesis of diabetic retinopathy.
- Insulin resistance and renal function in hypertension.
- Prognosis and osteodystrophy of diabetic ESRD patients.
- What is learned from kidney biopsy findings No. 2. A case of uriniferous tubule interstitial nephritis with comparatively rapid progress.
- Effect of intravenous iron supplementation using cideferron (an iron preparation) in erythropoietin therapy for anemia in hemodialysis patients.
- The clinical effect of a .BETA.2-microglobulin adsorption column of direct hemoperfusion type [Lixelle] on dialysis-related-amyloidosis: A prospective multi-center controlled .BETA.2-microglobulin adsorption column study (.BETA.MACS).
- A case of renal vein thrombosis.
- Laparoscopic rescue of encapsulated peritoneal dialysis catheter; A case report.
5
- Blood purification: Principles, methods and indications.
- An overview of dialysis treatment in Japan.
- Present status of peritoneal dialysis: Actual situation and future perpectives in Japan.
- Kidney transplantation: Cooperation with dialysis therapy.
- The pilot study of DGR-Based prospectived payment system in Japan and its application to renal dialysis therapy.
- Principles of renal failure and dialysis treatment.
- Recent progress on the anti-coagulant for hemodialysis.
- Components of dialysate for hemodialysis. History of dialysate.
- Membrane types of dialyzers(filters) and those selection standards.
- Vascular access: Variations and complications.
- The improvement of devices of peritoneal dialysis and complications during long term therapy.
- Anemia of endstage renal disease.
- Strategies against bone disease in chronic dialysis.
- Dialysis Amyloidosis.
- Complications of cardiovascular system and arteriosclerosis.
- Abnormalities of blood pressure(hypertension and hypotension).
- Acquired cystic disease of the kidney.
- Abnormalities of lipid metabolism in hemodialysis patients.
- Immunological disorder and infectious diseases.
- What is the adequate hemodialysis? Indices for performance of adequate hemodialysis.
- Key points in the treatment of diabetic renal failure.
- The knack of taking care of pediatric patients with chronic renal failure.
- Clinical management in aged dialysis patients.
- The effect of renal transplantation on the secondary hyperparathyroidism of chronic renal failure.
- The effect of pravastatin on renal function and lipid metabolism in hypertensive patients with renal dysfunction and hyperlipidemia.
- A case of postrenal acute renal failure induced with idiopathic retroperitoneal fibrosis.
6
- Overview of urolithiasis in Japan.
- Pathogenesis of urolithiasis in adult.
- Causes of nephrocalcinosis and urolithiasis in children.
- Oxalate metabolism in urolithiasis.
- Inhibitors of calcium oxalate crystals.
- Pathogenesis of urolithiasis.
- Imaging of urolithiasis.
- Biochemical analysis of blood and urine in urolithiasis.
- Analysis of urinary calculi.
- Recent trend in the treatment of urinary calculi by extracorporeal shock were lithotripsy.
- Endoscopic(endourological) surgery: PNL and TUL.
- Current status of open surgeryt for upper urinary tract stones.
- Treatment of urolithiasis in children.
- Medical treatment of urolithiasis.
- Clinical effects of prophylactic dietary treatment on renal stones.
- Diagnostic imaging technique in case of communicative hydrocele after introduction to peritoneal dialysis.
- Clinical effect of new cellulose triacetate membrane with microgradient structure for hemodialysis.
- A case of SLE complicated with lupus cystitis developing hydronephrosis.
47
- Condition of HDF popularization. From the viewpoint of clinicians.
- Introduction to peritoneal function test.
- What has changed with high performance membrane ? Achievement point of high performance membrane.
- Abnormalities of urine color and transparency.
- What has changed in high performance membrane ? Clinical effects and problems of high performance membrane.
- Cause and steps for prolonged peritonitis.
- Proteinuria.
- What has changed in high performance membrane ? Hemodialysis membrane and lipid metabolism.
- Condition of HDF popularization. From the viewpoint of manufacturers.
- Clinical study of removal and replacement of peritoneal catheter on resistant peritonitis in CAPD patients for the purpose of preventing SEP.
- Hematuria.
- What has changed in high performance membrane ? Carbonyl stress and high performance membrane.
- What has changed in high performance membrane ? What has changed by purification of dialysis fluid ?
- Considering insurance application for HDF therapy.
- Pyuria and bacteriuria.
- Treatment of relapsing peritonitis in CAPD patients.
- What has changed in high performance membrane ? HPM changes survival rate and crisis risk of dialysis amyloidosis.
- Glycosuria.
- Dialysis fluid pollution by couplers. Clean couplers and silicon couplers.
- Recurrent peritonitis in CAPD patients. Pathophysiology and treatment.
- Polyuria and oliguria.
- Performance evaluation of membrane (1). Studies on features of BIOREX AM-BC-150X with symmetrical gradient pore structure.
- Evaluation of pollution control couplers.
- Disturbance of urination.
- Performance evaluation of membrane (1). On suppressive effect of BIOREX AM-BC-150X on invation of dialysis fluid.
- Endogeneous peritonitis: A study of peritoneal dialysis related peritonitis caused by Gram negative bacteria.
- Safety management in O n -l ine HDF operation. Merits and demerits of management practical fulltimers.
- Performance evaluation of membrane (1). Performance evaluation of new PAES membrane MM-15.
- Scavenging effect of R O films by oxygen system detergents.
- Signs and symptoms: edema, dehydration.
- Fungal peritonitis.
- Performance evaluation of membrane (1). Comparison with performance of new synthetic polymer membrane MM-15 (TEIJIN Gambro AB Co.) and various dialyzers.
- Residual renal function and urine volume in patients with continuous ambulatory peritoneal dialysis.
- Electrolyte disorders.
- Evaluation of economical efficiency and maintenance by R O equipment improvement. Introduction of R O water recycling continuous running system
- Performance evaluation of membrane (1). Clinical evaluation of symmetrical gradient structure membrane Comparative examination with FB-U.
- Practice of slightly acidic electrolytic generation aqueous solution in hemodialysis.
- Decline of residual renal function in patients of automated peritoneal dialysis.
- A clinical application of continuous recirculating peritoneal dialysis.
- Performance evaluation of membrane (2). Long term use experience of FB-150FH.
- Acid-base abnormalities.
- Long term use evaluation of endotoxin cut filters ( micro ET ).
- Performance evaluation of membrane (2). Confirmation of safety of hydrophilic PEPA membrane dialyzer NXF-15GW and clinical evaluation.
- The availability of 6-days a week CAPD therapy.
- Performance evaluation of Lymurus reagent for dialysis fluid measurement.
- Skin symptoms and signs.
- Performance evaluation of membrane (2). Examination on plasma proteins which are adsorbed and filtered in polysulfone membranes of each manufacturer.
- Combined therapy with peritoneal dialysis(PD) and hemodialysis(HD) is beneficial in CAPD.
- Comparison between adsorption and passage of endotoxin to various dialysis membranes.
- Ocular manifestations(renal retinopathy).
- Performance evaluation of membrane (2). Protein adsorption properties of polysulfone and cellulose triacetate membranes.
- Effect of combined therapy with intermittent 3 days' peritoneal resting and hemodialysis on the peritoneal ultrafiltration failure.
- Microbial control in O n -l ine HDF dilute solution. Relation between LAL , SLP method and raw bacteria.
- Deafness.
- Sensory disturbance.
- Performance evaluation of membrane (3). Performance evaluation of polysulfone membrane (PS-H) with suppressing albumin leakage and examination on low molecular weight protein removability.
- Comparison between improved APS films and usual-model APS films. Comparison of solute removal performance.
- The exit site care with sealing film for CAPD patients.
- Abdominal pain, lumbago, and back pain.
- Comparative study of various polysulfone film dialyzers at massive pre-dilution o n -l ine HDF.
- A new device for the prevention and the treatment of tunnel infection.
- Performance evaluation of membrane (3). Clinical evaluation of polysulfone membrane dialyzer F70S.
- Bone and joint pain.
- Efficacy of hypertonic saline for the treatment of exit-site skin in CAPD patients.
- Performance evaluation of membrane (3). Performance evaluation of polysulfone membrane BS-U type.
- Relationship between p l asma refi ll ing and urea removal dynamics at O n -l ine HDF.
- Pyrexia.
- Performance evaluation of membrane (4). Performance comparison (APS-130S) of improved PS membrane.
- Skin pH acid mantle in CAPD patients.
- Anemia.
- Selection of filtration films for purpose of cytokine removal.
- Performance evaluation of membrane (4). Biocompatibility and performance evaluation of improved APS (polysulfone) membrane.
- Study of influencial factors on solute removal characters of inside filtration accelerated hemodialyzers.
- Abnormalities of blood pressure(hypertension and hypotension).
- Performance evaluation of membrane (4). Evaluation of APS-150S.
- Exit site infection in CAPD patients.
- Performance evaluation of membrane (4). Clinical performance evaluation of large pore size polysulfone dialyzer.
- Trial of o n -l ine HDF of indivisual dialysate apparatus DBB - 72 by NIKKISO Co..
- Observation of white matter on CAPD catheter inside tunnel.
- Growth retardation.
- A case report of a preliminary stage of shifting to sclerosing encapsulating peritonitis(SEP) treated successfully with steroid therapy.
- Performance evaluation of membrane (4). Clinical evaluation of polyether sulfone membrane dialyzer KD-150.
- Proper substitution volume and execution times in maintenance HDF therapy using post-dilution method o ff -l ine HDF. Clinical effectiveness and removal efficiency for lo w v ol ume HDF.
- Children(school urinalysis).
- Sclerosing peritonitis successfully treated by steroid therapy: A report of 2 cases.
- Comparison of membranes. Comparative examinations of polysulfone membrane dialyzer PS-1.6UW and CL-PS 15N on performance for removal of solutes.
- Experience of HDF (HDF hybrid system) using bi-dialyzers.
- The study for the prediction of the onset of sclerosing encapsulating peritonitis(SEP).
- Mass screening in adults.
- Comparison of membranes. Examination of removal performance of low molecular weight proteins (LMWP) from the standpoint of albumin loss in various PS membranes.
- Two cases of sclerosing encapsulating peritonitis successfully treated by surgical management.
- Comparison of membranes. Examination of biocompatibility of various polysulfone membrane dialyzers.
- Effect of O n -l ine HDF therapy on anemia.
- Urogenital organs.
- Comparison between improved APS films and usual-model APS films. Time-dependent variation rate of peripheral blood leukocyte counts during HDF.
- Comparison of membranes. Performance evaluation of various PS membranes.
- Therapeutic strategy for sclerosing encapsulating peritonitis.
- Clinical evaluation of Push/Pu ll HDF treatment for 2 years.
- Renal biopsy for primary renal diseases.
- The interruption cases of CAPD without removed peritoneal catheter.
- Comparison of membranes. Clinical performance evaluation of polysulfone (PS) membrane dialyzer and APS-180 and BS-1.8P.
- The lower abdominal incision for retrieving catheter obstructon by omental wrapping in a CAPD patient.
- Yearly transition of osteoarthralgia and bone cysts of long term continuous cases in massive substitution push & pu ll (P/P)HDF.
- Renal biopsy for secondary nephropathies.
- Comparison of membranes. Comparative examination on performance for removal of solutes of polysulfone membrane BS-1.6P and PS-1.6N.
- Biopsy for the diagnosis of urological diseases.
- Lower abdominal approach using hemicircled, coiled, single cuff peritoneal catheter with short abdominal segment.
- Urinary cytology.
- Medical practice. Effects of dilution system and filtration flow rate in On-line HDF on removal of solutes.
- Manipulation of inserted index finger into lower abdominal incision for catheter tip migration with poor drainage.
- Medical practice.Importance of .BETA.2MG removal method in chronic artificial kidney therapy.
- Diet therapy(for renal disease).
- Physical and morphological changes in PD catheters with use.
- Medical practice. On erythrocyte life span of dialysis patients.
- Loop S catheter (new S shaped curled CAPD catheter): Features and clinical experience.
- Drug therapy on renal diseases.
- Medical practice. Studies on ET passage of polysulfone membrane.
- Peritoneal catheter with a single cuff: Clinical experiences in 18 PD patients.
- Infusion therapy.
- Medical practice. Does changes from polylsulfone memebrane to regenerated cellulose film make serum lipid exacerbate ?
- Clinical report of the utility of CAPDIAL collagen-cuff in 7 cases.
- Blood purification treatments.
- Two cases of femoral head fracture in CAPD patients.
- Vital reaction. Analysis of peripheral blood monocyte CD14+CD16+ cell in hemodialysis patients.
- Kidney transplantation.
- An experience of parathyroidectomies in patients on CAPD with normal calcium dialysate.
- Vital reaction. Effect of cleanliness of dialysis fluid on serum solubile CD14 concentration.
- Vital reaction. Effect of cellulose triacetate (CTA) membrane on expression of monocyte CD14 and blood S-CD14 level.
- Effective CAPD treatment for refractory ascites in a patient with chronic renal failure complicating liver cirrhosis.
- Vital reaction. A consideration on anaphylactoid reaction in polysulfone membrane.
- Asymptomatic hematuria and proteinuria.
- Treatment for intractable ascites with CAPD in end-stage renal failure patient due to lupus nephritis.
- Biocompatibility. Antioxidant effect of vitamin E immobilized dialyzer in maintenance dialysis patients.
- Poststreptococcal acute glomerulonephritis.
- A usefulness of CAPD for two intractable cases.
- Biocompatibility. Examination on effect of dialysis membrane biocompatibility on carbonyl stress.
- Treatment of refractory ascites with peritoneal dialysis-Evaluation of the efficiency of peritoneal dialysis.
- IgA nephropathy.
- Biocompatibility. On usefulness of high performance membrane in removal of Di-(2-ethylhexyl)phthalate dissolved from blood circuits.
- Membranous nephropathy.
- Incidence and complications of abdominal wall hernia during CAPD.
- Membranoproliferative glomerulonephritis.
- Therapeutic technique. Transition of serum .BETA.2-microglobulin concentration in use of hemoperfusion adsorption column (Recucel) .
- A case of CAPD patient associated with a cyclic thrombocytopenia.
- Focal segmental glomerular sclerosis(FSGS).
- Risk factors of CAPD.
- Therapeutic technique. Changes of .BETA.2MG value with large internal filtration in bipartite dialyzer dialysis and examination on subjective symptom.
- Rapidly progressive glomerulonephritis.
- Draw up a questionnaire for patients with CAPD.
- Therapeutic technique. Examination on reverse filtration accelerated HDF using bipartite dialyzer.
- ANCA related/associated glomerulonephritis.
- Importance of familial assessment from an phase on hospitalization: A case generally entrusted CAPD to his family.
- Goodpasture syndrome.
- Extra-site care using elastic net in patients of skin allergy for a sticking plaster.
- Next generation artificial kidney and others. Proof of carbonyl stress in blood of renal insufficiency.
- Henoch-Schoenlein purpura nephritis.
- Next generation artificial kidney and other. Improvement in remaining blood for noticing header indoor blood stream.
- HBV,HCV,HIV-associated nephropathy.
- The body size influences the relationship between Kt/V for urea and creatinine clearance in peritoneal dialysis.
- Evidence that gender difference affects the peritoneal dialysis capacity.
- Next generation artificial kidney and other. Manufacture of hybrid artificial kidney (filtrated liquid regeneration system) using tubular cells and evaluation of electrolytes transport.
- Idiopathic nephrotic syndrome-adult.
- Minimal change nephrotic syndrome in children.
- Peritoneal function analysis of CAPD patients by using personal dialysis capacity(PDC).
- Congenital nephrotic syndrome.
- Analysis of peritoneal function in 205 Japanese CAPD-patients using personal dialysis capacity test.
- Fanconi syndrome.
- Application of PET-D/D0 curve using the ratio of the dialysate volume to the body fluid volume.
- Idiopathic low molecular weight proteinuria.
- Effect of combined therapy with peritoneal dialysis(PD) and hemodialysis(HD) on the peritoneal function.
- Renal hypouricemia.
- Charge-selective peritoneal equilibration test: a new test to assess peritoneal solute transport.
- Renal tubular acidosis.
- Prognosis and yearly changes in hyaluronan and CA125 in the peritoneal effluent.
- Bartter's syndrome and Gitelman's syndrome.
- The effects of glucose and heparin on the metabolism of collagen on the peritoneal fibroblasts.
- Liddle's syndrome.
- Pseudohypoaldosteronism.
- Expression of heat-shock protein 47 in cultured human peritoneal mesothelial cells.
- Nephrogenic diabetes insipidus.
- Interstitial nephritis.
- The efficacy of low calcium dialysate to parathyroid in CAPD patients.
- Oligosaccharides as osmotic agents for more efficient fluid removal in PD.
- Nephrotoxicity due to drugs and heavy metals.
- Change of abdominal computerized tomography in a patient on CAPD with ileus after tuberculous peritonitis.
- Lupus nephritis.
- Microbial fragments in peritoneal dialysate effluents.
- Renal involvements in collagen diseases.
- Two PD patients with Serratia peritonitis in whom transfer to hemodialysis was necessitated-With some thoughts on therapeutic strategy of Serratia peritonitis.
- Rapidly growing mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis: Case report and a review of literature.
- Multiple myeloma and cryoglobulin associated nephropathy.
- Renal amyloidosis.
- A case of polycystic kidney disease complicated by intracystic hemorrhage successfully treated with percutaneous ethanol injection therapy.
- Immunotactoid glomerulopathy and fibrillary glomerulonephritis.
- A case of CAPD patient recovered the ultrafiltration failure by tranexamic acid administration.
- Diabetic nephropathy.
- Plasma zinc increases in CAPD patients with gastric ulcer, treated with polaprezinc containing zinc 33.9mg/daily dose.
- Incidence of gingival hyperplasia caused by calcium channel blocker in patients on CAPD.
- Gouty kidney.
- A case of continuous ambulatory peritoneal dialysis maintaind by original imagination.
- Preeclampsia.
- Visiting nutritional education for patients on CAPD.
- Disseminated intravascular coagulation.
- A nursing case of 91-year-old woman undergoing CAPD treatment.
- Hemolytic uremic syndrome.
- CAPD in elderly patients.
- Cyanotic glomerulopathy.
- Efficiency of peritoneal dialysis in old aged CRF patients.
- Renal infarction, renal vein thrombosis, renal cortical necrosis, renal papillary necrosis.
- Familial benign hematuria.
- A case study of a patient spend majority of his time pron.
- Alport syndrome.
- A case report: A CAPD patient who was not sufficiently supported by the present home medical treatment and care system.
- Lipoprotein glomerulopathy.
- Utilization of public welfare facilities in care-requiring PD patients.
- Essential hypertension.
- Support of a blind patient treated with continuous ambulatory peritoneal dialysis.
- Support for the self-reliance of the young patient who under goes CAPD.
- Guidelines of the management of renal parenchymal hypertension in JNC-VI.
- Adaptation of APD for patients with CAPD.
- Renovascular hypertension.
- Present state and QOL in patients on automated peritonedialysis.
- 2 years experience of "My Home PD" Terumo APD cycler to drain an undrainded dialysate totally at the end of nocturnal APD.
- Endocrine hypertension.
- A case of chronic renal failure with multiple organ failure successfully treated by continuous peritoneal dialysis.
- Combined therapy of CAPD and HD in apatient with severe left ventricular systolic dysfunction.
- Pyelonephritis.
- Inflammatory diseases related to pyelonephritis.
- Four cases that developed marked cardiomegaly during CAPD but improved after changing to hemodialysis.
- The use of nightly automated peritoneal dialysis(NPD) for the body fluid control in children with intractable nephrotic edema.
- Treatment regimens for bacterial cystitis.
- Hemorrhagic cystitis, radiation cystitis, eosinophiric cystitis, emphysematous cystitis.
- Vitamin B6 deficiency in patients on continuous ambulatory peritoneal dialysis(CAPD).
- Prostatitis.
- Plasma branched chain amino acid in CAPD patients.
- Orchitis and epididymitis.
- Tuberculosis of urinary tract.
- Pentosidine in continuous ambulatory peritoneal dialysis patients.
- Sexually transmitted diseases.
- The methods and problems of CAPD waste disposal in Yamagata prefecture.
- Multicystic dysplastic kidney.
- A counterplan of garbage in continuus peritoneal dialysis system.
- Polycystic kidney: Autosomal dominant and recessive.
- Telemedia and internet systems for the management of CAPD patients.
- Solid and multiple renal cysts.
- The role of pharmacist for CAPD patients.
- Tuberous sclerosis.
- Comparison of QOL between peritoneal dialysis and hemodialysis by KDQOL-SF.
- Von Hippel-Lindau disease.
- Peritoneal dialysis '99. Laboratory reports for CAPD patients.
- Medullary sponge kidney.
- Hydronephrosis.
- Intermittent hydronephrosis.
- Peritoneal dialysis '99. Field study of home CAPD related waste treatment.
- Urethral stricture.
- Vesicoureteral reflux(VUR).
- Vascular disorders of the kidney renal arteriovenous fistula, renal artery aneurysm.
- Horseshoe kidney, ureterocele, and cloacal exstrophy.
- Diagnosis of upper and lower urinary tract calculi.
- Treatment of urolithiasis.
- Renal tumours in adult.
- Wilms' tumor.
- Transitional cell cancer of renal pelvis, ureter, and urinary bladder.
- Benign prostatic hyperplasia.
- Treatment strategy for prostate cancer.
- Neoplasms of the testis, the epididymis and the penis.
- Renal trauma.
- Injury of ureter, bladder and urethra.
- Trauma of testis and penis.
- Neuropathic bladder disorders.
- Urinary frequency(nocturnal frequency).
- Difficulty of urination(urinary retention).
- Urinary Incontinence.
- Nocturnal enuresis.
- Male infertility.
- Impotence.
- Acute renal failure(prerenal-, renal-, and postrenal renal failure).
- Chronic renal failure.
- Hypertension and hypotension.
- Ischemic heart disease, arrhythmia and sudden death in chronic dialysis patients.
- Cerebrovascular accidents in dialysis patients.
- Congestive heart failure in dialysis patients.
- Neurological disorders associated with renal failure and dialysis.
- Treatment of anemia by rHuEPO in patients undergoing long-term dialysis.
- Ocular complication.
- Diseases of the skin in dialysis patients.
- Complications of bone and joint lesion in patients with hemodialysis.
- Infection.
- CAPD related peritonitis.
- Sclerosing encapsulating peritonitis:SEP.
- Renal tumor in dialysis patients.
- Psychological approach of renal disease.
- Psychological aspects in pediatric nephrology.
- Psychosomatic medicine and disease in the urology.
- Malingering, Munchausen syndrome, Munchausen syndrome by proxy.
1
- Concept of ANCA related glomerulonephritis.
- The detection of ANCA and the target antigens.
- Animal model of ANCA associated glomerulonephritis.
- The epidemiology of ANCA related glomerulonephritis.
- Clinical features of ANCA related glomerulonephritis.
- Clinical features in pediatric patients with anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis.
- Therapeutic strategy of ANCA associated glomerulonephritis.
- Prognosis of glomerulonephritis caused by anti-neutrophil cytoplasmic autoantibodies.
- Systemic sclerosis and ANCA related glomerulonephritis.
- ANCA related glomerulonephritis induced by anti-thyroid drug.
- Anti-glomerular basement membrane nephritis and ANCA-associated nephritis.
- Is ANCA a true villain, or just playing it?
- Extra-renal disorders in ANCA associated nephritis.
- Shunt troubleshooting : My way. 1. Dissection and physiology for arteriovenous in the limbs.
- What is learned from kidney biopsy findings ? No. 3. A case with clinical course of late pure pregnant toxemia and recognizing dense dep o sit in the glomerulus by electron microscope.
- Effects of nicotinamide and nicomol on serum phosphate concentration in hemodialysis patients.
- Effects of nipradilol on blood pressure, renal function and proteinuria in patients with chronic renal disease.
- Minimal change nephrotic syndrome with acute tubulointerstitial nephritis due to non steroidal anti-inflammatory drug.
- A case of nephrotic syndrome with membranoproliferative glomerulonephritis like lesion after esophagectomy for esophageal cancer.
2
- Cell and developmental biology of mesangial cells.
- Properties of the glomerular mesangium.
- The modulation of glomerular hemodynamics by mesangial cells.
- Expressed gene profile of human mesangial cells and mesangial cell-predominant gene.
- Binding between glomerular mesangial cells and extracellular matrix.
- Role of TGF-.BETA. in mesangial cells.
- Cytokines related with the mesangial proliferation.
- The relationship between mesangial cell cycle progression and E2F.
- Physical force and mesangial cells.
- Role of angiotensin II and nitric oxide in glomerular mesangial cells.
- Regulation of glomerular extracellular matrix metabolism.
- Cell-Cell interactions of glomerular endothelial cells and mesangial cells.
- Histopathology of mesangial proliferation.
- Mesangiolysis.
- Phenotypic change of human mesangial cells.
- Lipids.
- Hyperglycemia-induced mesangial cell dysfunction in diabetes.
- All of mesangium cells. Do mesangium lesions come to glomerulosclerosis ? Ap o pt o sis.
- Shunt troubleshooting. My way 2. Skin incision and care for nerves.
- Endotoxin removal therapy (PMX) for the treatment of severe sepsis and accompanied renal replacement therapy. Improvements of organ dysfunction.
- Manifestation of shunt nephritis 14 years after insertion of ventriculoatrial(V-A) shunt.
3
- Overview: Drug-induced nephrotoxicity.
- Approach for amelioration of drug-induced nephropathy.
- Drug-induced nephritis and allergy.
- Role for reactive oxygen for the nephrotoxicity induced by drug.
- Drug-induced nephropathy and cytokines.
- Antibiotics induced acute tubulointerstitial nephritis.
- NSAID nephrotoxicity.
- Strategy against the contrast-media induced nephropathy.
- Prevention and management of nephrotoxicity from anti-cancer agents.
- Nephrotoxicity of immunosuppressive agents.
- Renal disorders induced by DMARs in patients with rheumatoid arthritis.
- Drug induced nephropathy in children.
- Drug induced renal damage in elder people.
- Shunt troubleshooting. My way. 3. For no failures in primary operation.
- Early experience with a carbon-PTFE graft for hemodialysis.
- Effects of peritoneal dialysis solution pH on phagocytosis, reactive oxygen intermediates generation and cytokine release of human peripheral blood mononuclear cells.
- A randomized study of pain by subcutaneous administration of two type of recombinant human erythropoietin preparations.
4
- The role of transplant surgeons on the treatment for renal transplant recipients.
- The role of renal physician.
- The role of pediatric nephrologist.
- A system of transplant medicine-A role of psychiatrists.
- The role of organ transplant coordinator.
- Social worker's activities for the transplant patienels and families.
- Risk factors for the long-term renal transplant survival; multivariate analysis.
- Histological analysis in renal allografts surviving long-term after teransplantation.
- Pathogenesis and therapeutic strategy of chronic rejection.
- Urinary tract infection and obstructive disease of urinary tract in kidney transplantation.
- Hyperlipidemia.
- Hypertension and arteriosclerosis.
- Liver dysfunction.
- Systemic infection in kidney transplant recipients.
- Complication and treatment-Malignant tumors.
- Diet therapy to renal trasplanted patients.
- Shunt troubleshooting. My way 4. Countermeasures for twitching are key of success.
- Safety evaluation of polaprezinc in dialysis patients accompanied by gastric mucosa damage.
- Bone histomorphometric effect of 22-oxacalcitriol(OCT) on secondary hyperparathyroidism of hemodialysis patients.
- A case of parathyroid carcinoma in patient on long term hemodialysis with secondary hyperparathyroidism.
5
- Calcium sensing recepter. Physiological significance of Ca receptor.
- Calcium sensing recepter. Ca sensing receptor: structural motif sensing Ca2+.
- Calcium sensing recepter. The mechanism of signal transduction by CaSR.
- Calcium sensing recepter. Localization and function of the extracellular Ca/polyvalent cation-sensing protein in kidney.
- Calcium sensing recepter. Distribution and function of calcium sensing receptor in parathyroid gland.
- Calcium sensing recepter. Calcium sensing receptor in the bone.
- Calcium sensing recepter. Localization and function of the calcium sensing receptor in organs other than kidney, parathyroid and bone.
- Calcium sensing recepter. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
- Calcium sensing recepter. Autosomal dominant hypocalcemia.
- Calcium sensing recepter. Primary hyperparathyroidism.
- Calcium sensing recepter. Renal secondary hyperparathyroidism.
- Calcium sensing recepter. Pharmacological characteristics of calcimimetics.
- Calcium sensing recepter. Potential for the development of calcilytics.
- Calcium sensing recepter. Clinical effect of calcimimetics.
- Hypertension in Pregnancy.
- Clinicopathological and immnohistochemical studies in patients with preeclamptic nephropathy.
- Antiphospholipid syndrome and pregnancy.
- Diabetes and pregnancy.
- Evaluation of plasma concentration of mizoribine as an immunosuppressive agent in lupus nephritis patients.
- Enquete study of intravenous intermittent cyclophosphamide bolus therapy(IVCY) in patients with lupus nephritis.
- Effect of 22-Oxacalcitriol(OCT) injection for treatment of secondary hyperparathyroidism in renal insufficiency patients undergoing dialysis.
- A case with complete remission of nephrotic syndrome after removal of a total hydatidiform mole.
- A case with acute renal failure, rhabdomyolysis and tetanic convulsions, subsequent to intermittent vomiting.
6
- Dialysis-related amyloidosis.
- Precursor protein of dialysis-related amyloidosis.
- Modification of .BETA.2-microglobulin.
- AGE modified .BETA.2 microglobulin.
- Methods of AGE determinations.
- Physical and biochemical findings.
- Radiological findings of dialysis-related arthropathy.
- Pathological examinations.
- Drug therapy.
- Dialysis and filtration therapy.
- Adsorption therapy for the treatment of dialysis-related amyloidosis.
- Orthopaedic complications in dialysis-associated amyloidosis patients.
- Kidney transplantation for prevention and treatment of dialysis-related amyloidosis.
- Clinical experience of cyclophosphamide intravenous bolus therapy in 5 patients with intractable diffuse lupus nephritis.
- Development of competitive ELISA methode for plasma pentosidine concentration and the analysis of the patients with chronic renal failure.
- A case of Xanthinuria type I.
| Copyright (c) 2006-2007 Japan Science and Technology Agency. All Rights Reserved. | |
